Olaf Kinstler
19Patents
11h-index
19Co-inventors
65Inventor score
Filing activity: Jul 29, 1994 → Dec 16, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5824784A | N-terminally chemically modified protein compositions and methods | Human Necessities | 367 | Expired |
| US6586398B1 | Chemically modified novel erythropoietin stimulating protein compositions and methods | Human Necessities | 170 | Expired |
| US6420339B1 | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility | Human Necessities | 160 | Expired |
| US5985265A | N-terminally chemically modified protein compositions and methods | Human Necessities | 98 | Expired |
| US5766581A | Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation | Emerging Cross-Sectional Technologies | 82 | Expired |
| US5795569A | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5574018A | Conjugates of vitamin B12 and proteins | Human Necessities | 44 | Expired |
| US7160924B2 | Protein conjugates with a water-soluble biocompatible, biodegradable polymer | Human Necessities | 34 | Expired |
| US7662933B2 | N-terminally chemically modified protein compositions and methods | Human Necessities | 33 | Active |
| US5770577A | BDNF and NT-3 polypeptides selectively linked to polyethylene glycol | Emerging Cross-Sectional Technologies | 30 | Expired |
| US5900404A | Chemical modification of proteins to improve biocompatibility and bioactivity | Human Necessities | 21 | Expired |
| US8143380B2 | Therapeutic peptides | Human Necessities | 11 | Expired |
| US6956027B2 | N-terminally chemically modified protein compositions and methods | Human Necessities | 11 | Expired |
| US6017876A | Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity | Human Necessities | 9 | Expired |
| US6204247A | Chemical modification of proteins to improve biocompatibility and bioactivity | Human Necessities | 6 | Expired |
| US7262166B2 | Chemically modified novel erythropoietin stimulating protein compositions and methods | Human Necessities | 4 | Expired |
| US8258262B2 | N-terminally chemically modified protein compositions and methods | Human Necessities | 3 | Active |
| US6420340B2 | Chemical modification of proteins to improve biocompatibility and bioactivity | Human Necessities | 2 | Expired |
| US6770746B2 | Chemical modification of proteins to improve biocompatibility and bioactivity | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.